VSIR and neoplasm: Interestingly, in this study, we found that VISTA was significantly expressed in both TCs and ICs (42% vs 48%) as reported by other studies, which showed that in EOC, VISTA was observed in both tumor-infiltrating immune cells and tumor cells [3, 10], unlike the other tumors where it is more commonly expressed in tumor-infiltrating immune cells.